What is Spyre Therapeutics, Inc. Common Stock's Market Cap?

Spyre Therapeutics, Inc. Common Stock's Market Cap is $7.8B, based on as-reported figures from SEC (XBRL) filings.

What is Spyre Therapeutics, Inc. Common Stock's Revenue (TTM)?

Spyre Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Spyre Therapeutics, Inc. Common Stock's Net Income (TTM)?

Spyre Therapeutics, Inc. Common Stock's Net Income (TTM) is -$178.9M, based on as-reported figures from SEC (XBRL) filings.

What is Spyre Therapeutics, Inc. Common Stock's EBITDA?

Spyre Therapeutics, Inc. Common Stock's EBITDA is -$201.3M, based on as-reported figures from SEC (XBRL) filings.

What is Spyre Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Spyre Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.03, based on as-reported figures from SEC (XBRL) filings.

Spyre Therapeutics, Inc. Common Stock (SYRE) Financial Statements

Spyre Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG0067L94C1

XNAS · usd

88.31▼ 2.48 (-2.73%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close90.79

Day's Range85.00 – 92.10

52-Week Range14.51 – 110.18

Volume1.2M

Avg Volume1.0M

Share Statistics

Shares Outstanding

Employees102

ExchangeXNAS

Listed2016-04-07

Share count as of July 28, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Spyre Therapeutics, Inc. Common Stock (SYRE)

What is Spyre Therapeutics, Inc. Common Stock's Market Cap?: Spyre Therapeutics, Inc. Common Stock's Market Cap is $7.8B, based on as-reported figures from SEC (XBRL) filings.
What is Spyre Therapeutics, Inc. Common Stock's Revenue (TTM)?: Spyre Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Spyre Therapeutics, Inc. Common Stock's Net Income (TTM)?: Spyre Therapeutics, Inc. Common Stock's Net Income (TTM) is -$178.9M, based on as-reported figures from SEC (XBRL) filings.
What is Spyre Therapeutics, Inc. Common Stock's EBITDA?: Spyre Therapeutics, Inc. Common Stock's EBITDA is -$201.3M, based on as-reported figures from SEC (XBRL) filings.
What is Spyre Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Spyre Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.03, based on as-reported figures from SEC (XBRL) filings.